Ticker archive · $PVLA

$PVLA Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $PVLA — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$PVLA

$PVLA – Palvella Therapeutics Receives FDA Priority Review for QTORIN Rapamycin NDA

PALVELLA THERAPEUTICS, INC.

2026-10-28 00:00:00 UTC · SEC_8K · All $PVLA

?? Positive AI Sentiment (+6.8 / 10)

FDA accepted NDA with Priority Review for QTORIN 3.9% rapamycin in microcystic lymphatic malformations.
PDUFA target action date set for February 28, 2027.
Phase 3 SELVA trial met all six prespecified endpoints (p<0.001).

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?